An open Challenge that merges the efforts of the world’s largest cancer genome sequencing consortia, the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) with those of Sage Bionetworks and DREAM.
Toronto – November 3, 2013. The International Cancer Genome Consortium (ICGC) today announced a new project from Singapore to identify the genomic drivers in biliary tract cancer (cholangiocarcinoma/gall bladder cancer), which will improve the understanding and clinical management of these rare diseases.
TORONTO, ON (November 1, 2013) – The Ontario Tumour Bank (OTB) will supply ovarian tumour samples to the Canadian Ovarian Cancer Experimental Unified Resource (COEUR) in an effort to further enhance ovarian cancer research in Canada, announced Dr. John Bartlett, Provincial Principal Investigator, OTB and Director of the Ontario Institute for Cancer Research’s (OICR) Transformative Pathology Program.
TORONTO, ON (June 28, 2013) — Dr. Calvin R. Stiller, Chair of the Board of Directors of the Ontario Institute for Cancer Research (OICR), today congratulated Dr. Thomas J. Hudson, OICR’s President and Scientific Director, on behalf of the Board, on his appointment as an Officer of the Order of Canada.
TORONTO, ON (June 24, 2013) —The Ontario Institute for Cancer Research (OICR) is investing $52 million to support the development of new innovative approaches for the prevention, early detection, diagnosis, and treatment of cancer. The announcement was made today by Ontario Minister of Research and Innovation Reza Moridi.
TORONTO, ON (June 20, 2013) – Dr. Calvin Stiller, Chair of the Board of Directors of
the Ontario Institute for Cancer Research (OICR) today announced the appointment
of Robert N. Klein to OICR’s Board of Directors.
Mr. Klein initiated California’s Proposition 71, a $3 billion ballot initiative that
established the California Institute for Regenerative Medicine (CIRM). He served as
Chairman of the Governing Board of CIRM for its first seven years and was elected
Chairman Emeritus for the organization in 2011. He has been a member of Genome
Toronto, Ontario (June 11, 2013) — Dr. Catharine Whiteside, Dean of the University of Toronto Faculty of Medicine and Vice Provost, Relations with Health Care Institutions, today announced that seven of Toronto’s leading research organizations have joined together in an unprecedented global alliance of more than 70 organizations engaging over 40 countries around the world. The alliance aims to set new, unified standards for managing and sharing of genomic and clinical data to enable rapid progress in biomedical research and to advance human health.
Toronto, Ontario – June 4, 2013. Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR), congratulates Dr. Geoffrey Fong who received a World Health Organization (WHO) World No Tobacco Day Award in a ceremony in Washington DC on May 31, 2013. Dr. Fong is an OICR Senior Investigator and Professor of the Department of Psychology and the School of Public Health and Health Systems at the University of Waterloo.
TORONTO, ON (April 25, 2013) – The Ontario Institute for Cancer Research (OICR) and the Ontario Genomics Institute (OGI) today announced that Dr. Lincoln Stein, OICR’s Program Leader, Informatics and Bio-computing, has been awarded $250,000 through Genome Canada’s Bioinformatics and Computational Biology competition, in partnership with the Canadian Institutes of Health Research (CIHR). Dr. Stein and his colleague Dr.
TORONTO, ON (April 25, 2013) – Dr. Nicole Onetto, Deputy Director and Chief Scientific Officer of the Ontario Institute for Cancer Research (OICR), today announced that OICR has been selected by the Canadian Partnership Against Cancer (CPAC) to develop the coordinating centre for the Canadian Cancer Clinical Trials Network (CCCTN). Dr. Janet Dancey, OICR’s Director of the High Impact Clinical Trials Program, will be the Scientific Director and lead the CCCTN coordinating centre. The collaborating organizations are the NCIC Clinical Trials Group and N2 (Network of Networks).